Novel Cancer Vaccine May Improve Survival in Synovial Sarcoma
Pharma & biotech2018-06-26
19 Views
Investigators are hopeful that CMB305, a vaccine that boosts the immune response to tumor cells expressing the antigen NY-ESO-1, can improve survival outcomes for patients with synovial sarcoma.
Source: OncLive
The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.
Sponsored Post
Pass Microsoft MTA Certification Exams to Gain Entry into IT Industry
